Clinical Trial Update: Evaluation of a Novel Insulin Sensitizer in People With Type 1 Diabetes [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating a novel insulin sensitizer in people with Type 1 diabetes mellitus is currently recruiting to assess glycemic control and rela…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 1 Diabetes Mellitus

Snippet

Sponsor: University of Virginia | Conditions: Type 1 Diabetes (T1D), Glycemic Control for Diabetes Mellitus | Phase 2 | Status: RECRUITING